Convexia
PrivateLast Round
Seed
Jul 25, 2025
Total Funding Raised
$1M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Convexia is a healthcare company that provides an AI-driven platform for pharmaceutical drug discovery, asset sourcing, and clinical development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Convexia Comparables
Compare Convexia with similar companies based on industry and business-model similarity.
Convexia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 25, 2025 |
Convexia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Y Combinator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Grew 133% QoQ from 3 to 7 employees.
- Mar 3, 2026
Monthly visitors grew 71% MoM, from 3.4K to 5.9K.
Convexia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Convexia's valuation, stock price, and market status.